P2Y2- and P2Y4 purinergic receptors are over-expressed in human colon cancer
G Nylund1, L Hultman, S Nordgren
1Department of Surgery, Kungälv District Hospital, SE-442 83 Kungälv, Sweden.
Abstract:
1. A characteristic of cancer is altered signal transduction leading to uninhibited growth. Adenosine-5'-triphosphate (ATP), a natural ligand at P2X- and P2Y purinergic receptors may regulate cell growth in non-neoplastic, as well as neoplastic tissues. In the human colon cancer cell line, HT-29, we previously demonstrated the expression of purinergic receptors of the P2Y(2)- and P2Y(4) subclasses. 2. The aim of the current study was to investigate whether these two purinergic receptors are expressed also in human colon cancer, and, if so, how such expression is related to that in tumour-free colonic tissue. 3. The immunohistochemical findings of both P2Y(2)- and P2Y(4) receptors in the tumours from three patients, prompted us to conduct an investigation of a consecutive series of patients utilizing Western blotting for protein detection and densitometry for quantitation. 4. Both P2Y(2)- and P2Y(4) purinergic receptors could be identified in tumour-free tissue, and both were significantly over-expressed in each of the 10 colon cancers.
Insights
Colon cancer exhibits over-expressed P2Y(2) and P2Y(4) purinergic receptors compared to normal tissue. This suggests these receptors play a role in the uninhibited growth characteristic of colon cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Cancer is characterized by altered signal transduction pathways promoting uncontrolled cell proliferation.
- Adenosine-5'-triphosphate (ATP) acts as a ligand for P2X and P2Y purinergic receptors, potentially regulating cell growth in both normal and cancerous tissues.
- Previous studies identified P2Y(2) and P2Y(4) purinergic receptor expression in the HT-29 human colon cancer cell line.
Purpose of the Study:
- To investigate the expression of P2Y(2) and P2Y(4) purinergic receptors in human colon cancer tissue.
- To compare the expression levels of these receptors in cancerous tissue versus adjacent tumor-free colonic tissue.
Main Methods:
- Immunohistochemistry was initially used to detect P2Y(2) and P2Y(4) receptor expression in tumor samples.
- Western blotting and densitometry were employed for protein detection and quantification in a larger series of patients.
Main Results:
- Both P2Y(2) and P2Y(4) purinergic receptors were detected in tumor-free colonic tissue.
- A significant over-expression of both P2Y(2) and P2Y(4) purinergic receptors was observed in all 10 colon cancer samples analyzed.
Conclusions:
- P2Y(2) and P2Y(4) purinergic receptors are present in both normal and cancerous human colon tissues.
- These receptors are significantly over-expressed in colon cancer, suggesting a potential role in the pathogenesis and progression of the disease.
Related Concept Videos
Abnormal Proliferation
Mitogens and the Cell Cycle
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Selectins
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
